HOME >> MEDICINE >> NEWS
NIAID releases MDR/XDR Tuberculosis research agenda

WHAT: The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), today released its NIAID Research Agenda for Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis (TB). While focusing on MDR/XDR TB, many of the research priorities identified in this document also relate to drug-sensitive tuberculosis. The research priorities identified in the agenda build on a foundation of ongoing NIAID-supported TB research, which currently comprises more than 300 research projects worldwide.

Diagnosing, treating and controlling the spread of TB has become increasingly complicated because of the HIV/AIDS co-epidemic and the emergence of MDR and XDR TB, which threatens to set TB control efforts back to the pre-antibiotic era. According to NIAID Director Anthony S. Fauci, M.D., NIAID developed this TB research agenda to address MDR/XDR TB with appropriate urgency, while reaffirming the Institutes commitment to a robust program of research focused on all aspects of TB. NIAID is well prepared to foster the development of new TB diagnostics, drugs and vaccines, but given the realities of MDR/XDR TB, the research agenda outlines those areas that need additional attention to enable public health officials to more effectively combat all forms of tuberculosis, he says. He notes that the agenda is a Web-based living document that can be updated as scientific and public health needs and opportunities evolve.

NIAID collaborated with other government and non-government experts to prepare the MDR/XDR TB research agenda. In addition to its review by TB specialists in academia, advocacy groups, international organizations and other government agencies, the draft agenda was presented to the National Advisory Allergy and Infectious Diseases Council, NIAIDs main scientific advisory body.

The research agenda specifically describes six critical areas where additional investiga
'"/>

Contact: Jason Bardi
jbardi@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
6-Jun-2007


Page: 1 2

Related medicine news :

1. NIAID DNA vaccine for H5N1 avian influenza enters human trial
2. NIAID media availability: Examining genetic variability of malaria parasite offers insight
3. NIAID awards $4 million to develop anti-radiation treatments
4. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
5. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/13/2018)... ... ... Pulsara is honored to be represented by its CEO, Dr. James Woodson, ... Chicago. Dr. Woodson, ER Physician and Founder/CEO of Pulsara, has been invited to ... & Collaboration (CC&C) is Not Enough: Why You Need a Regional Communication Network.” , ...
(Date:9/12/2018)... ... , ... Donaldson Plastic Surgery has been included on the Inc. 5000 list ... list of central Ohio's fastest growing businesses. The plastic surgery practice was ranked number ... is the only medical practice and plastic surgery office to make the regional Fast ...
(Date:9/7/2018)... (PRWEB) , ... September 07, 2018 , ... ... Community College District , the only OSHA authorized OTI Education Center headquartered in ... to assist employees who feel they have experienced retaliation in response to engaging ...
(Date:9/2/2018)... (PRWEB) , ... September 02, 2018 , ... ... merges hospitality with positive social change. The hotel itself, which opened this week, ... thought leaders, innovators, lawmakers or more. , Eaton Hotel DC currently features 209 ...
(Date:9/1/2018)... ... 01, 2018 , ... September is Animal Pain Awareness Month, ... (IVAPM) that aims to encourage pain management for all animals through education and ... pet owners of the many forms of pain and the importance of pain ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... ... 2018 , ... This September is Centers for Disease Control and Prevention’s ... on how to help prevent food poisoning. According to the CDC, every year, an ... and 3,000 die from eating contaminated food. In support of the campaign, Best Sanitizers ...
(Date:9/13/2018)... ... September 13, 2018 , ... NCPDP announced today ... and ensure correct implementation of the NCPDP SCRIPT Standard Version 2017071 ahead of ... and transactions identified by the industry as vital enhancements in improving patient safety, ...
(Date:9/13/2018)... ... September 13, 2018 , ... ... a specialist pharmaceutical company focused on developing and commercializing gastrointestinal therapeutics, has ... product. , The U.S. Food and Drug Administration (FDA) and European Medicines ...
Breaking Medicine Technology:
Cached News: